Skip to main content
Livermore
Livermore
ZHEN

Profund Advisors LLC

SEC CIK
0001129919
Latest filing
Aug 11, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
21,747
Value
$1.70M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of HALO by Profund Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202621,747$1.70M<0.1%−10,768−33.1%ReducedHolders
Q1 202632,515$2.10M0.1%−3,585−9.9%ReducedHolders
Q4 202536,100$2.43M0.1%+11,469+46.6%AddedHolders
Q3 202524,631$1.81M0.1%−13,809−35.9%ReducedHolders
Q2 202538,440$2.00M0.1%+11,021+40.2%AddedHolders
Q1 202527,419$1.75M0.1%−18,274−40.0%ReducedHolders
Q4 202445,693$2.18M0.1%+4,323+10.4%AddedHolders
Q3 202441,370$2.37M0.1%+11,939+40.6%AddedHolders
Q2 202429,431$1.54M0.1%−11,915−28.8%ReducedHolders
Q1 202441,346$1.68M0.1%−1,558−3.6%ReducedHolders
Q4 202342,904$1.59M0.1%−1,348−3.0%ReducedHolders
Q3 202344,252$1.69M0.1%−5,969−11.9%ReducedHolders
Q2 202350,221$1.81M0.1%+13,293+36.0%AddedHolders
Q1 202336,928$1.41M0.1%+14,216+62.6%AddedHolders
Q4 202222,712$1.29M0.1%−76−0.3%ReducedHolders
Q3 202222,788$901.0K0.1%−442−1.9%ReducedHolders
Q2 202223,230$1.02M0.1%−3,988−14.7%ReducedHolders
Q1 202227,218$1.08M<0.1%−3,094−10.2%ReducedHolders
Q4 202130,312$1.22M<0.1%−3,755−11.0%ReducedHolders
Q3 202134,067$1.39M<0.1%+22,844+203.5%AddedHolders
Q2 202111,223$511.0K<0.1%+307+2.8%AddedHolders
Q1 202110,916$455.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.